Dr Lee Krug Explains How Trials Work

In this conference video from 2014 from the Mesothelioma Applied Research Foundation channel, Dr. H. Richard Alexander, of the University of Maryland, alongside Lee Krug, MD of the Memorial Sloan-Kettering Cancer Center, discuss the state of mesothelioma research during the Symposium on Malignant Mesothelioma.

Dr. H. Richard Alexander focuses on discussing scientific researches funded by federal grants and by the Mesothelioma Applied Research Foundation, and briefly talks about the key points in each scientific research proposal that was granted funding.

During this lecture, Dr. H. Richard explains how he sees immunology and “molecular targets” as a “step in the right direction” towards the possible cure for mesothelioma in the long run.

Afterwards, Dr. Lee Krug explains the process of a new drug being approved by the FDA, and how many challenges and difficulties are presented to actually pass the test phases and trials.

He also talks about placebo usage in trials and the difficulties that patients may have to endure while being promised a possible treatment and being given a placebo, instead of a real testing treatment.

Finally, he also explains the differences in trial designs for the same disease.

Learn more about mesothelioma here: http://bit.ly/MesoRN

Mesothelioma Research News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Leave a Comment

Your email address will not be published.

Verify you are not a robot